The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Generalized anxiety disorder and the Hamilton Anxiety Rating Scale in Parkinson's disease
Open accessAbstract
UNLABELLED: Anxiety is common in Parkinson's disease (PD), but studies concerning specific anxiety disorders are scarce. Essential psychometric properties of anxiety rating scales are also lacking. OBJECTIVE: To investigate general anxiety disorder (GAD) in PD and psychometric properties of the Hamilton Anxiety Rating Scale (Ham-A). METHOD: Ninety-one PD patients underwent neurological and psychiatric examination, which included the MINI-Plus, the Ham-A and the Hamilton Depression Rating Scale (Ham-D). RESULTS: GAD was present in 30.8% of PD patients. Patients with GAD had longer disease duration (p=0.044) and were in use of higher doses of levodopa (p=0.034). They also tended to have more motor fluctuations and dyskinesias. The group with GAD scored higher in Ham-A (p<0.001), in the somatic (p=0.004) and psychic (p<0.001) subscales of Ham-A, and in Ham-D (p=0.004). The Ham-A showed good internal consistency (Cronbach's alpha=0.893) and a cutoff score of 10/11 is suggested to screen for GAD. CONCLUSION: GAD is frequent in PD and the Ham-A may be a useful instrument to screen for this disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Anxiety symptom severity was measured using the Brazilian Portuguese version (Kummer et al., 2010) of the Hamilton Anxiety Scale (HAM-A) (Hamilton, 1959).”
From Inflammatory markers changes following acceptance-based behavioral psychotherapy in generalized anxiety disorder patients: Evidence from a randomized controlled trial (2024) · cites this paper as Kummer et al., 2010
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Also, HRSA demonstrated good internal consistency, indicating an alpha coefficient of 0.89 (Kummer et al., 2010).”
From Standard CBT versus integrative and multimodal CBT assisted by virtual-reality for generalized anxiety disorder (2022) · cites this paper as Kummer et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Sugestões para o uso do mini-exame do estado mental no Brasil
Brucki, S. M. D., Nitríni, R., Caramelli, P., Bertolucci, P. H. F., & Okamoto, I. H. (2003) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2003000500014 · Cited by 2,236
Samii, A., Nutt, J. G., & Ransom, B. R. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16305-8 · Cited by 1,361
Amorim, P. (2000) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462000000300003 · Cited by 1,085
Depression rating scales in Parkinson's disease: Critique and recommendations
Schrag, A. E., Barone, P., Brown, R. G., Leentjens, A. F. G., McDonald, W. M., STARKSTEIN, S. E., Weintraub, D. A., Poewe, W. H., Rascol, O., Sampaio, C., et al. (2007) · Movement Disorders · doi:10.1002/mds.21333 · Cited by 690
Quality of life in Parkinson's disease: the relative importance of the symptoms
Rahman, S., Griffin, H. J., Quinn, N. P., & Jahanshahi, M. (2008) · Movement Disorders · doi:10.1002/mds.21667 · Cited by 532
Shear, M. K., Vander Bilt, J., Rucci, P., Endicott, J., Lydiard, B., Otto, M. W., Pollack, M. H., Chandler, L., Williams, J., Ali, A., et al. (2001) · Depression and Anxiety · doi:10.1002/da.1033 · Cited by 483
The quality of life in Parkinson's disease
Kuopio, A., Marttila, R. J., Helenius, H. Y. M., Toivonen, M., & Rinne, U. K. (2000) · Movement Disorders · doi:10.1002/1531-8257(200003)15:2 · Cited by 321
Research works printed but not linked: 4
- Shiba M, 2000, Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study, Mov Disord, 15, 669
- Brucki SM, 2003, Suggestions for utilization of the mini-mental state examination in Brazil, Arq Neuropsiquiatr, 61, 777
- McRae C, 2000, Schwab & England: standardization of administration, Mov Disord, 15, 335
- Kurlan R, 1989, Panic/anxiety in Parkinson's disease: yohimbine challenge [abstract], Neurology, 39
Cited by
Sorted by citations
Tovilla‐Zárate, C. A., Juárez‐Rojop, I. E., Peralta-Jiménez, Y., Jiménez, M. A., Vázquez, S., Bermudez‐Ocaña, D. Y., Ramón-Frías, T., Mendoza, A. D. G., García, S. P., & López‐Narváez, M. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036887 · Cited by 143
“Although the scale assesses a broad range of symptoms, it is most frequently used to assess the severity of general anxiety disorder [35,36].”
BackgroundThe clinical spectrum of anxiety in Parkinson's disease
Dissanayaka, N. N. N. W., White, E., O'Sullivan, J. D., Marsh, R., Pachana, N. A., & Byrne, G. J. (2014) · Movement Disorders · doi:10.1002/mds.25937 · Cited by 124
“Duration of PD diagnosis is positively correlated with anxiety in a number of studies.(11,12,20,28,33,89,90) In contrast, Leentjens et al.”
BackgroundInfluentialAnxiety and depression in patients with Parkinson's disease.
Yamanishi, T., Tachibana, H., Oguru, M., Matsui, K., Toda, K., Okuda, B., & Oka, N. (2013) · Internal medicine · doi:10.2169/internalmedicine.52.8617 · Cited by 123
Depression and Anxiety Disorders in Patients With Inflammatory Bowel Disease
Hu, S., Chen, Y., Chen, Y., & Wang, C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.714057 · Cited by 94
“Through continuous use of the scale, doctors can evaluate the results of medication or psychotherapy (38).”
BackgroundAnxiety rating scales in Parkinson's disease: a critical review updating recent literature
Dissanayaka, N. N. W., Torbey, E., & Pachana, N. A. (2015) · International Psychogeriatrics · doi:10.1017/s1041610215000885 · Cited by 74
“A limitation of Kummer et al. (2010), however, is that the mean age of the sample was 57.2 years while the mean age of PD onset was 48.4 years, suggesting this sample was not representative of the older age and PD onset in typical PD samples.”
BackgroundMethodInfluentialNeuropsychiatric characteristics of GBA-associated Parkinson disease
Swan, M. C., Doan, N., Ortega, R., Barrett, M. J., Nichols, W. C., Ozelius, L. J., Soto‐Valencia, J., Boschung, S., Deik, A., Sarva, H., et al. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.08.059 · Cited by 64
“Risk of depression and anxiety in PD may be affected by sex (32– 34, 37), age at onset (32, 53), and disease duration (35, 49, 54).”
BackgroundDisease-specific anxiety symptomatology in Parkinson's disease
Dissanayaka, N. N., O’Sullivan, J. D., Pachana, N. A., Marsh, R., Silburn, P. A., White, E., Torbey, E., Mellick, G. D., Copland, D. A., & Byrne, G. J. (2016) · International Psychogeriatrics · doi:10.1017/s1041610215002410 · Cited by 59
“(Stein et al., 1990; Menza et al., 1993; Lauterbach et al., 2003; 2004; Pontone et al., 2009; Chen et al., 2010; Dissanayaka et al., 2010; Kummer et al., 2010; Leentjens et al., 2011a; 2012; Qureshi et al., 2012).”
Apathy in Neurodegenerative Diseases
Cummings, J. L., Friedman, J. H., Garibaldi, G. M., Jones, M., Macfadden, W., Marsh, L., & Robert, P. H. (2015) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988715573534 · Cited by 55
Pandey, S., Bajaj, B. K., Wadhwa, A., & Anand, K. S. (2016) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2016.06.014 · Cited by 46
Severity of oral lichen planus and oral lichenoid lesions is associated with anxiety
Zucoloto, M. L., Shibakura, M. E. W., Pavanin, J. V., Garcia, F. T., Santos, P. S. D. S., Maciel, A. P., Gallo, C. D. B., Vilela, N., Innocentini, L. M. A. R., Humberto, J. S. M., et al. (2019) · Clinical Oral Investigations · doi:10.1007/s00784-019-02892-2 · Cited by 43
Characteristics and Treatment of Anxiety Disorders in Parkinson's Disease
Dissanayaka, N. N., White, E., O’Sullivan, J. D., Marsh, R., Silburn, P. A., Copland, D. A., Mellick, G. D., & Byrne, G. J. (2015) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12157 · Cited by 39
“Whereas some studies have demonstrated a positive correlation between anxiety and duration of PD, others have shown no association.(1,8,9,32,36,37) Consistent with previous studies,(1,8,9,32,36,37) we did not find an association between anxiety and LEDD.”
ResultDetecting anxiety in individuals with Parkinson disease
Mele, B., Holroyd-Leduc, J. M., Smith, E. E., Pringsheim, T. M., Ismail, Z., & Goodarzi, Z. (2017) · Neurology · doi:10.1212/wnl.0000000000004771 · Cited by 36
“When a cutoff of 10/11 was used, the HARS had similar sensitivity (86%) but lower specificity (64%) than the GAI.(25) As the HARS was developed to monitor the progression of anxiety, it may be better utilized for follow-up screening.”
MethodRasch analysis of anxiety scales in Parkinson's disease
Forjaz, M. J., Martínez‐Martín, P., Dujardin, K., Marsh, L., Richard, I. H., STARKSTEIN, S. E., & Leentjens, A. F. G. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.02.009 · Cited by 30
“Recent validation studies of these anxiety scales in PD patients demonstrated good results for some, but not all, parameters [7–11].”
ResultFu, C., Zhang, H., Xuan, A., Gao, Y., Xu, J., & Shi, D. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6434 · Cited by 31
“The inter-group differences in the HAM-D and HAM-A scores were statistically significant.”
MethodShahrokhi, M., Ghaeli, P., Arya, P., Shakiba, A., Noormandi, A., Soleimani, M., & Esfandbod, M. (2021) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.12.1.1650.2 · Cited by 28
Revisão sistemática de instrumentos para avaliação de ansiedade na população brasileira
DeSousa, D. A., Moreno, A. L., Gauer, G., Manfro, G. G., & Koller, S. H. (2013) · Dialnet (Universidad de la Rioja) · Cited by 27
Zhu, Y., Yang, B., Zhou, C., Gao, C., Hu, Y., Yin, W. F., Yin, K., Zhu, Y., Jiang, G., Ren, H. J., et al. (2022) · Brain Imaging and Behavior · doi:10.1007/s11682-022-00714-w · Cited by 27
“No regions showed decreased connectivity to the right lingual region (Table 3; * P value < 0.05 Abbreviations: CI, cognitive impairment; HC, healthy controls; MCI, mild cognitive impairment; MNI, Montreal Neurological Institute; NC, normal cognition; PD, Parkinson’s disease; PDD, Parkinson’s disease-associated dementi…”
MethodInfluentialManagement of anxiety and motor symptoms in Parkinson’s disease
Coakeley, S., Martens, K. A. E., & Almeida, Q. J. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.936388 · Cited by 25
“A similar positive correlation was found in a study regarding GAD in PD and L-DOPA dosage [27].”
BackgroundResultUnderstanding, Impact, and Communication of “Off” Periods in Parkinson's Disease: A Scoping Review
Rastgardani, T., Armstrong, M. J., Gagliardi, A. R., & Marras, C. (2018) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12672 · Cited by 24
Clinical Presentation of Anxiety in Parkinson’s Disease
Lutz, S. G., Holmes, J. D., Ready, E. A., Jenkins, M. E., & Johnson, A. M. (2016) · OTJR Occupational Therapy Journal of Research · doi:10.1177/1539449216661714 · Cited by 24
Efficacy of an acceptance-based group behavioral therapy for generalized anxiety disorder.
Almeida Sampaio, T. P., Jorge, R. C., Martins, D. S., Gandarela, L. M., Hayes‐Skelton, S., Bernik, M. A., & Lotufo‐Neto, F. (2020) · Depression and Anxiety · doi:10.1002/da.23021 · Cited by 23
Medeiros, G. C., Sampaio, D. G., Leppink, E. W., Chamberlain, S. R., & Grant, J. E. (2016) · Journal of Behavioral Addictions · doi:10.1556/2006.5.2016.044 · Cited by 23
Clinical Rating Scales and Quantitative Assessments of Movement Disorders
Tarakad, A. (2020) · Neurologic Clinics · doi:10.1016/j.ncl.2019.12.001 · Cited by 22
Lai, C., Luciani, M., Galli, F., Morelli, E., Moriconi, F., Penco, I., Aceto, P., & Lombardo, L. (2016) · Journal of Mental Health · doi:10.3109/09638237.2016.1167855 · Cited by 18
“The Hamilton Anxiety Rating Scale HAM-A (Hamilton, 1959) was used to rate the severity of the anxiety using 14 Likert’s items; it showed a good internal consistency (Cronbach’s a ¼ 0.89) (Kummer et al., 2010).”
MethodInfluentialRisk factors for visual hallucinations in patients with Parkinson’s disease
Gama, R. L., de Bruin, V. M. S., de Bruin, P. F. C., Távora, D. G. F., Lopes, E. M. S., Jorge, I. F., Bittencourt, L., & Tufik, S. B. (2014) · Neurological Research · doi:10.1179/1743132814y.0000000418 · Cited by 17
Xavier, A. C. M., de Souza, C. M. B., Flores, L. H. F., Bermúdez, M. B., Silva, R. M. F., de Oliveira, A. C., & Dreher, C. B. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2019-0636 · Cited by 17
Popa, C. O., Sava, F. A., Muresan, S., Schenk, A., Cojocaru, C. M., Muntean, L. M., & Olah, P. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.1008981 · Cited by 14
Group Nutrition Counseling or Individualized Prescription for Women With Obesity? A Clinical Trial
Bolognese, M. A., Franco, C. B., Ferrari, A., Bennemann, R. M., Lopes, S. M. A., Bertolini, S. M. M. G., Nardo, N., & Branco, B. H. M. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00127 · Cited by 14
“Scores ≥ 18 were defined as mild anxiety; ≥ 25, moderate anxiety; and≥ 30, severe anxiety (40).”
BackgroundProgression of Fatigue in Early Parkinson’s Disease: A 3-Year Prospective Cohort Study
Ou, R., Hou, Y., Liu, K., Lin, J., Jiang, Z., Wei, Q., Zhang, L., Cao, B., Zhao, B., Song, W., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.701906 · Cited by 14
Fatigue in Parkinson’s Disease Associates with Lower Ambulatory Diastolic Blood Pressure
Kotagal, V., Szpara, A., Albin, R. L., & Bohnen, N. I. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-191579 · Cited by 14
“The 30item Geriatric Depression Scale (GDS) was used to measure symptoms of depression [12], the Hamilton Anxiety Rating Scale (HAM-A) was used to measure symptoms of anxiety [13], the Survey of Autonomic Symptoms was used to measure symptoms of dysautonomia [14], and the Epworth Sleepiness Scale was used to measure s…”
MethodMuthuraman, K., Sankaran, A., & Subramanian, K. (2024) · Indian Journal of Psychological Medicine · doi:10.1177/02537176231223304 · Cited by 14
Birling, Y., Nevitt, S. J., Bhuyan, D. J., Jia, M., Feng, F., Carlson, L. E., Pham, T., Liu, J., Ayati, Z., Nyiam, L., et al. (2021) · Methods and Protocols · doi:10.3390/mps4040076 · Cited by 13
“The accepted assessment tools with validated cut-off scores are: (1) GAD-7 score ≥ 8 [70]; (2) HAMA score ≥ 11 [71]; (3) BAI score ≥ 12”
MethodGiron, S. E., Bjurström, M. F., Griffis, C. A., Ferrante, F. M., Wu, I., Chadwick, A. L., Grogan, T., Burkard, J. F., Irwin, M. R., & Breen, E. C. (2017) · Pain Medicine · doi:10.1093/pm/pnx126 · Cited by 12
Sleep quality is associated with the severity of clinical symptoms in Parkinson’s disease
Junho, B. T., Kümmer, A., Cardoso, F., Teixeira, A. L., & Rocha, N. P. (2017) · Acta Neurologica Belgica · doi:10.1007/s13760-017-0868-6 · Cited by 12
Malghani, P. G., Abbasi, L. S., Majeed, S., & Saleem, T. (2021) · Journal of Dental Education · doi:10.1002/jdd.12751 · Cited by 11
Relaxation and Hypnosis in Reducing Anxious-depressive Symptoms and Insomnia among Adults
Holdevici, I. (2014) · Procedia - Social and Behavioral Sciences · doi:10.1016/j.sbspro.2014.03.315 · Cited by 11
“The Ham-A showed good internal consistency (Cronbach's alpha=0.89) and a cutoff score of 10/11 is suggested to screen for GAD (Kummer et al., 2010).”
BackgroundInfluentialWiglusz, M. S., Landowski, J., & Cubała, W. J. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.02.017 · Cited by 11
Psychiatric disorders in primary focal dystonia and in Parkinson’s disease
Teixeira, A. L., Dias, F. M. V., Kümmer, A., Doyle, Harsanyi, Cardoso, & Fontenelle, L. F. (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s17507 · Cited by 10
Behavioral disorders in Parkinson disease: current view
Jellinger, K. (2024) · Journal of neural transmission · doi:10.1007/s00702-024-02846-3 · Cited by 10
“Anxiety has been reported in 20–40% of PD patients (Upneja et al. 2021), usually ranging between 28 and 31% (Betrouni et al. 2022; Carey et al. 2020; Kummer et al. 2010; Yassine et al. 2024), with an overall prevalence of 31% (Dissanayaka et al. 2022), whereas others reported around 40% (Chen et…”
Craiovan, P. M. (2015) · Procedia - Social and Behavioral Sciences · doi:10.1016/j.sbspro.2015.03.044 · Cited by 9
“The Ham-A showed good internal consistency (Cronbach's alpha=0.89) and a cutoff score of 10/11 is suggested to screen for GAD (Kummer et al., 2010).”
BackgroundInfluentialBhagavan, C., Glue, P., Evans, W., Reynolds, L., Turner, T., King, C., Russell, B. R., Morunga, E., Mills, J. L., Layton, G., et al. (2024) · Trials · doi:10.1186/s13063-024-08174-x · Cited by 10
“The HAM-A has demonstrated good reliability (Cronbach’s alpha = 0.89), and its psychic and somatic subscales have also demonstrated good internal consistency (Cronbach’s alpha = 0.83 and 0.80 respectively) [76].”
MethodInfluentialSlater, P. F., Bunting, B., Hasson, F., Al‐Smadi, A. M., Gammouh, O. S., Ashour, A. F., & Jordan, D. (2019) · International Journal of Research in Nursing · doi:10.3844/ijrnsp.2019.1.9 · Cited by 8
“…al., 2010; García-Campayo et al., 2012; Erge et al., 2016; Chouhan et al., 2016) and utilised in a range of clinical conditions (Capuron et al., 2002; Kersting et al., 2004; Gençöz et al., 2007; Garalejić et al 2010; Kummer et al., 2010; Chouhan et al., 2016; Erge et al., 2016; Yang et al., 2017).”
BackgroundMethodInfluential伊藤, 和., & Audi, L. (2021) · Journal of Health Sciences · doi:10.17532/jhsci.2021.1191 · Cited by 8
Avendaño, C. A. N., Ospina, J. M., & Abril, F. G. M. (2014) · Areandina · doi:10.33132/01248146.47 · Cited by 7
Gandarela, L., de A. Sampaio, T. P., Marçal, L., Burdmann, E. A., Neto, F. L., & Bernik, M. A. (2024) · Brain, Behavior, & Immunity - Health · doi:10.1016/j.bbih.2024.100779 · Cited by 6
“Anxiety symptom severity was measured using the Brazilian Portuguese version (Kummer et al., 2010) of the Hamilton Anxiety Scale (HAM-A) (Hamilton, 1959).”
MethodManzoor, S., Rakha, A., Rasheed, H., Munir, S., Abdi, G., Bhat, Z. F., & Aadil, R. M. (2024) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2024.101029 · Cited by 8
Low back pain: biopsychosocial aspects of chronic and acute pain
ALEXANDRE, B. D., & Serafini, A. J. (2022) · Estudos de Psicologia (Campinas) · doi:10.1590/1982-0275202239e200209 · Cited by 6
Lu, Y. (2024) · American Journal of Translational Research · doi:10.62347/mjpk6664 · Cited by 5
“The HAM-A showed good internal consistency, with a Cronbach’s alpha value of 0.893 [16].”
InfluentialTorres, R. F. D., Ludeña, J. E. P., & Dávila-Torres, G. A. (2020) · Acta Odontológica Colombiana · doi:10.15446/aoc.v10n3.89052 · Cited by 5
Gupta, A., Dere, S. S., & Ghildiyal, P. R. (2022) · Telangana Journal of Psychiatry · doi:10.4103/tjp.tjp_11_22 · Cited by 5
Liu, J., Li, G., He, Y., He, G., Zhang, P., Shen, X., Zhang, W., Chen, S., Cui, S., & Tan, Y. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00952 · Cited by 5
“The p-values were further assessed by Bonferroni correction of multiple tests (Bonferroni correction of multiple tests was conducted in 32 rating scales and sub-scales, such as SS16, HAMA, HAMD, MDS-UPDRS parts 1, 2, and 3, etc.; and 21 symptoms, such as dysphagia, sialorrhea, constipation, nocturia, etc).”
MethodInfluentialXavier, A. C. M., de Souza, C. M. B., Flores, L. H. F., Prati, C., Cassal, C., & Dreher, C. B. (2019) · Anais Brasileiros de Dermatologia · doi:10.1016/j.abd.2018.10.001 · Cited by 5
Assessment of Anxiety and Depressive Symptoms in the Early Post-stroke Period
Todorov, V., Dimitrova, M., Todorova, V., & Mihaylova, E. (2020) · Folia Medica · doi:10.3897/folmed.62.e49453 · Cited by 4
PSYCHOSOCIAL INSTRUMENTS FOR BRAZILIAN ELDERLY: A SCOPING REVIEW
da Silva, A., & Rebustini, F. (2021) · Psicologia Saúde & Doenças · doi:10.15309/21psd220231 · Cited by 4
From OCD Symptoms to Sleep Disorders: The Crucial Role of Vitamin B12
Wang, S., Zhang, X., Ding, Y., Wang, Y., Wu, C., Lu, S., & Fang, J. (2024) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s489021 · Cited by 3
Qian, X., Wu, L., & Xu, S. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03718-0 · Cited by 3
“The psychological scores (Hamilton Anxiety Scale) before and after treat-ment were compared between the two groups [16].”
Personality and Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson’s Disease
Daga, G. A., Marzola, E., Amianto, F., Zibetti, M., Merola, A., Lanotte, M., Lopiano, L., & Fassino, S. (2014) · International Neuropsychiatric Disease Journal · doi:10.9734/indj/2014/11740 · Cited by 3
“89 [41] and its test-retest reliability was good [42].”
BackgroundEfetividade da fisioterapia associada à musicoterapia na doença de Parkinson
Yamashita, F. C., Saito, T. C., de Almeida, I. A., Barboza, N. M., & Santos, S. M. S. (2013) · ConScientiae Saúde · doi:10.5585/conssaude.v11n4.3857 · Cited by 3
Atagün, M. İ., Atmaca, B., Özer, F., Özben, S., Tıraş, R., Çetin, S. E., & GENÇ, M. F. (2012) · Dusunen Adam The Journal of Psychiatry and Neurological Sciences · doi:10.5350/dajpn2013260103 · Cited by 3
The effect of mindfulness and metacognition on anxiety symptoms: a case-control study
Aydın, O., Obuća, F., Çakıroğlu, E., Ünal‐Aydın, P., & Esen-Danacı, A. (2022) · Middle East Current Psychiatry · doi:10.1186/s43045-022-00260-7 · Cited by 4
“89; [52]) and good inter-rater reliability as determined by an intra-class correlation coefficient of 0.”
MethodDeSousa, D. A. (2013) · Americanae (AECID Library) · Cited by 3
Phalgune Deepak, S., Govind, V., Sudhir, K., & Premendrakumar, S. (2019) · IP Indian Journal of Neurosciences · doi:10.18231/j.ijn.2019.005 · Cited by 2
Validity and reliability of the agentive steadfastness index
Vosloo, C., & van Staden, W. (2023) · International Journal of Psychology · doi:10.1002/ijop.13098 · Cited by 3
Wang, L., Yuan, Y., Wang, J., Shen, Y., Zhi, Y., Li, J., Wang, M., & Zhang, K. (2019) · PeerJ · doi:10.7717/peerj.7957 · Cited by 2
Yamada, P. D. A., Amaral-Felipe, K. M., Rodrigues, B. F., Cursino, M. P., Hallal, C. Z., & Faganello-Navega, F. R. (2016) · Motricidade · doi:10.6063/motricidade.7875 · Cited by 2
Nurses' Knowledge of Signs and Symptoms of Anxiety and AgitationPreprint
DiSano, C. (2015) · doi:10.28971/532015dc75 · Cited by 2
“In this study, the reliability of the HAM-A was 0.893, supportive of good internal consistency for use of the HAM-A as a tool to assess anxiety in patients with PD (Kummer et al., 2010).”
MethodInfluentialWang, Y., Gu, X., Zhi, B., Yan, Y., Lu, F., Hu, H.-T., & Zhang, Q. (2025) · PLoS ONE · doi:10.1371/journal.pone.0316804 · Cited by 2
Foo, M., Himawan, K. K., & Susanto, E. (2025) · Mental Health Review Journal · doi:10.1108/mhrj-01-2024-0003
Anxiety in Parkinson’s Disease
Dissanayaka, N. N. (2021) · Cambridge University Press eBooks · doi:10.1017/9781139087469.009 · Cited by 1
Mujović, N., Popovic, K., Janković, J., Mijatov, S. P., Mujović, N., Bogdanović, J. M., Stjepanović, M., Nikčević, L., Radosavljevic, N., & Nikolić, D. (2022) · Medicina · doi:10.3390/medicina58030392 · Cited by 1
“In our study we assessed separately: psychic component with psychic subscale (questions 1–6 and question 14) and somatic component by somatic subscale (questions 7–13) [20].”
MethodGeneralized anxiety causing globus pharyngeus
Thejas, S. R., Sharanya, J., & Rajamohan, G. (2023) · MRIMS Journal of Health Sciences · doi:10.4103/mjhs.mjhs_72_22 · Cited by 1
Utchimahali, S., Kannan, S., & Velayutham, K. (2024) · International Journal of Innovative Science and Research Technology (IJISRT) · doi:10.38124/ijisrt/ijisrt24aug927 · Cited by 1
Vieira, J. C. F. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2020.tde-11022020-153242 · Cited by 1
INDUÇÃO DE HUMOR POR REALIDADE VIRTUAL
BERNARDO, P. D. (2019) · doi:10.17771/pucrio.acad.46847 · Cited by 1
Ocorrência de sintomas depressivos e de ansiedade em fibromiálgicos
de Toledo, C. V., Antunes, M. D., Nishida, F. S., & de Oliveira, L. P. (2022) · Saúde e Desenvolvimento Humano · doi:10.18316/sdh.v10i1.8102
Specific neuropsychiatric disorders
Aarsland, D., Cummings, J. L., Weintraub, D., & Chaudhuri, К. R. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139856669.011
Psychoneuroimmunology and Chronic Pain
Giron, S. E. (2015) · doi:10.22371/07.2015.016
Yamashita, F. C., Saito, T. C., de Almeida, I. A., Mahmoud, S., & Santos, S. (2012)
Music Therapy for Preoperative Anxiety in Surgical Patients: An Integrative ReviewPreprint
Deuel, A. (2018) · doi:10.28971/532018da96
Relações entre ocitocina, apego e sono em pessoas com Transtorno de Ansiedade Generalizada
Vale, E. A. N. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.47.2019.tde-16082019-110304
Sampaio, T. P. D. A. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.47.2020.tde-28052020-192438
Xavier, A. C. M., de Souza, C. M. B., Flores, L. H. F., Prati, C., Cassal, C., & Dreher, C. B. (2019) · Anais Brasileiros de Dermatologia · doi:10.1016/j.abdp.2018.10.003
“Episódio depressivo atual 16 (25,4) Episódio depressivo passado 13 (20,6) Distimia 4 (6,3) Transtorno afetivo bipolar 6 (9,5) Transtorno de pânico 18 (28,6) Agorafobia 10 (15,9) Ansiedade social 6 (9,5)”
Avaliação em idosos: uma investigação sobre instrumentos de medida
da Silva, A. C. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.100.2021.tde-13052021-210249
Gandarela, L. M. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2021.tde-08122021-140003
Efeito Imediato da Fisioterapia na Marcha em Indivíduos com Doença de Parkinson
de Almeida, I. A., do Nascimento, T. S., Lemes, L. B., Batistetti, C. L., Ferraz, H. B., & Santos, S. M. S. (2015) · Saúde e Pesquisa · doi:10.17765/1983-1870.2015v8n2p247-253
Marsh, L., & Calleo, J. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139856669.012
de Oliveira, R. V., Moura, H. S., de Sousa, J. O., Schuelter‐Trevisol, F., & Trevisol, D. J. (2024) · Journal of Health Sciences · doi:10.17921/2447-8938.2024v26n2p106-114
Xu, Y.-L., Hu, Y., Luo, N., Sun, L., Xiao, X., Tang, L., & Li, Y. (2025) · Clinics · doi:10.1016/j.clinsp.2025.100820
Bhagavan, C., Glue, P., Evans, W., Reynolds, L., Turner, T., King, C., Russell, B. R., Morunga, E., Mills, J. L., Layton, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25876232
Bhagavan, C., Glue, P., Evans, W., Reynolds, L., Turner, T., King, C., Russell, B. R., Morunga, E., Mills, J. L., Layton, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25876328
Bhagavan, C., Glue, P., Evans, W., Reynolds, L., Turner, T., King, C., Russell, B. R., Morunga, E., Mills, J. L., Layton, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26723801
Utility of the SEND-PD Scale in Parkinson’s Disease: A Narrative Review
Hussain, J. M., Mubeen, M., Khan, S. M., Alauddin, S., Athar, F. B., Ellahi, D. M., Ali, Q., Khan, S. R., & Saleem, Z. (2025) · Brain Science Advances · doi:10.26599/bsa.2025.905004
“[9], panic disorder (22%), apathy (12.7%), and depression (13”
InfluentialKirk, A., King, C. S., Gallop, R., Doan, B. D., Rowe, L. S., Rivera, M., & Randa, L. E. (2026) · doi:10.2196/preprints.92448
Dar, S. A., Wani, R. A., Ruqaiya, & Raj, R. (2026) · Industrial Psychiatry Journal · doi:10.4103/ipj.ipj_250_25
Enhancing gait training with anti-gravity treadmill ‘Alter-G’ in patients with Parkinson’s disease
Latella, D., Facciale, A. L., Bonanno, M., Bonanno, L., Leo, A., Cellini, R., Lorenzo, G. D., Buonasera, P., Formica, C., Paladina, G., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0341021
“Higher scores indicate greater severity of anxiety symptoms [25].”
Gandarela, L. M., Sampaio, T. P. D. A., Marçal, L., Burdmann, E. A., Neto, F. L., & Bernik, M. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-08027-8
“The Brazilian Portuguese adapted version [17] of the Hamilton Anxiety Scale (HAM-A) [18] was used to measure the severity of anxiety symptoms.”
Kirk, A., King, C. S., Gallop, R., Doan, B. D., Rowe, L. S., & Randa, L. E. (2026) · JMIR Human Factors · doi:10.2196/92448
“The HAM-A has demonstrated good internal consistency (α=.89) [51].”
Metadata
- Authors
- Kummer, A., Cardoso, F., & Teixeira, A. L.
- Affiliations
- Federal University of Minas Gerais, Brazil
- Universidade Federal de Minas Gerais (BR)
- Federal University of Minas Gerais, Brazil; UFMG
- ORCID
- Cardoso, Francisco
- Venue
- Arquivos de Neuro-Psiquiatria
- Publisher
- FapUNIFESP (SciELO)
- Published
- 2010-08
- Volume
- 68
- Issue
- 4
- Pages
- 495-501
- ISSN
- 0004-282X (ISSN-L)
- OpenAlex
- W2000777554
- Cited by
- 103
- References
- 36
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 12 · 2023: 2 · 2022: 7 · 2021: 10 · 2020: 10 · 2019: 10 · 2018: 3 · 2017: 4 · 2016: 7 · 2015: 8 · 2014: 6 · 2013: 8 · 2012: 3
- FWCI
- 5.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Arquivos de Neuro-Psiquiatria (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- Americanae (AECID Library) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- generalized anxiety disorder, Parkinson's disease, Hamilton Anxiety Rating Scale, psychometric properties, anxiety screening, levodopa dose, motor fluctuations, dyskinesia, depression, internal consistency
- MeSH terms
- Anxiety Disorders, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Parkinson Disease, Psychiatric Status Rating Scales, Psychometrics, ROC Curve, Sensitivity and Specificity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review